Katoo Myllee
Real World Evidence Manager AstraZeneca
Seminars
Wednesday 25th February 2026
Panel Discussion: Data Access in Practice: Building Sustainable, Ethical, & Scalable RWE Across Europe
11:30 am
- How can pharma, registries, and vendors collaborate to avoid duplication and improve efficiency in finding usable datasets?
- What frameworks are needed to establish fair and transparent remuneration for physicians, patients, and database owners?
- How do we balance sustainability of smaller registries with industry’s need for scale and interoperability?
- How should pharma assess the risks of supporting new registries, and what funding and contracting models best incentivise long-term patient recruitment?
- Where can AI and automation play a role in reducing healthcare system burden and improving data timeliness?
Tuesday 24th February 2026
Mastering the Use & Quality Assessment of Secondary Health Data for RWE
This hands-on workshop will train you to critically evaluate the quality of secondary health data, navigate the overwhelming vendor landscape, and integrate data into robust study designs. Through interactive exercises and cross-industry discussion, participants will explore the full RWE journey, from accessing and structuring data to ensuring timely, transparent analyses that deliver value across clinical and commercial functions.
This workshop will gather experts to discuss:
- Recognising Pitfalls in Secondary Data – Common issues in claims, registries, and EHRs that compromise study validity
- Quality & Transparency – Understanding how data is structured, where algorithms differ, how often data is refreshed, and why vendors’ approaches vary
- Evaluating Fit-for-Purpose Data – How to critically assess vendor claims and avoid being misled by patient counts or incomplete variables
- Transparency & Accountability – Registering studies, sharing protocols, and ensuring openness in methodological decisions
- From Access to Application – Mapping the full RWE continuum: from data access to analysis and integration to decision-making
- Improving Vendor Collaboration – Ensuring scientific transparency, avoiding overengineering, and speeding time-to-insight
- Interactive Exercise – Applying a structured framework to assess a mock secondary data source and debate its fitness for a hypothetical RWE study
